e-learning
resources
Berlin 2001
Monday 24.09.2001
What can treatment of TB achieve?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of serum anti-tuberculous glycolipid antigen antibodies among the patients of tuberculous and nontuberculous pulmonary diseases
A. Nakamura, Y. Yamada, M. Itoh, M. Kajiura, T. Matsuura, K. Yoshitomo (Nagoya, Aichi, , Ichinomiya, Japan)
Source:
Annual Congress 2001 - What can treatment of TB achieve?
Session:
What can treatment of TB achieve?
Session type:
Poster Discussion
Number:
2254
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nakamura, Y. Yamada, M. Itoh, M. Kajiura, T. Matsuura, K. Yoshitomo (Nagoya, Aichi, , Ichinomiya, Japan). Comparison of serum anti-tuberculous glycolipid antigen antibodies among the patients of tuberculous and nontuberculous pulmonary diseases. Eur Respir J 2001; 16: Suppl. 31, 2254
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Assessment of specific immunoglobulins in patients with lung tuberculosis
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Detection of specific immunoglobulins against
Mycobacterium tuberculosis
in pleural fluid for the diagnosis of tuberculous pleurisy
Source: Annual Congress 2003 - Diagnosis of tuberculosis
Year: 2003
Serial sputum induction in nontuberculous mycobacterial pulmonary disease
Source: Eur Respir J, 55 (6) 1902196; 10.1183/13993003.02196-2019
Year: 2020
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005
Non tuberculous mycobacteria infections in patients with silicosis
Source: Virtual Congress 2020 – Occupational lung diseases
Year: 2020
Non tuberculous mycobacterial pulmonary disease in the elderly
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Autoantibodies in patients treated for active pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 159s
Year: 2003
Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients
Source: Eur Respir J 2006; 28: 1211-1215
Year: 2006
From detection of nontuberculous mycobacteria (NTM) in pulmonary specimens to pulmonary infections
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004
Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018
Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017
Pulmonary nontuberculous mycobacterial diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
Detection of various autoantibodies in patients with pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
The value of pleural fluid anti-A60 IgM in BCG vaccinated tuberculous pleurisy patients
Source: Eur Respir J 2002; 20: Suppl. 38, 581s
Year: 2002
Screening non-tuberculous mycobacteria in patients with bronchiectasis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept